Brincker H
Cancer Treat Rev. 1986 Sep;13(3):147-56. doi: 10.1016/0305-7372(86)90002-2.
Tumour-related tissue reactions resulting in the formation of epithelioid-cell granulomas have been known for almost 70 years. Such sarcoid reactions may occur in lymph-nodes draining an area housing a malignant tumour, in the tumour itself, and even in non-regional tissues. Overall, sarcoid reactions occur in 4.4% of carcinomas, in 13.8% of patients with Hodgkin's disease, and in 7.3% of cases of non-Hodgkin lymphomas. Similar histologic changes in sarcoma appear to be extremely rare. Most probably, sarcoid reactions are caused by antigenic factors derived from the tumour cells, eliciting an immunological hypersensitivity reaction leading to the formation of epithelioid-cell granulomas. Sarcoid reactions may be a marker of an immunologically mediated antitumour response of macrophages activated by T-lymphocytes, and in Hodgkin's disease there is evidence that patients with sarcoid reactions have a better prognosis. On occasion sarcoid reactions may be so extensive that they complicate the diagnosis of an underlying malignant disease. Problems may also arise of distinguishing between tumour-related sarcoid reactions and true systemic sarcoidosis.
导致上皮样细胞肉芽肿形成的肿瘤相关组织反应已为人所知近70年。这种类肉瘤反应可能发生在引流恶性肿瘤所在区域的淋巴结、肿瘤本身,甚至非局部组织中。总体而言,类肉瘤反应在4.4%的癌、13.8%的霍奇金病患者和7.3%的非霍奇金淋巴瘤病例中出现。肉瘤中类似的组织学变化似乎极为罕见。类肉瘤反应很可能是由肿瘤细胞衍生的抗原性因素引起的,引发免疫超敏反应,导致上皮样细胞肉芽肿的形成。类肉瘤反应可能是T淋巴细胞激活的巨噬细胞免疫介导的抗肿瘤反应的一个标志,在霍奇金病中,有证据表明有类肉瘤反应的患者预后较好。有时,类肉瘤反应可能非常广泛,以至于使潜在恶性疾病的诊断复杂化。区分肿瘤相关类肉瘤反应和真正的系统性结节病也可能出现问题。